Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300211
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7 Part of Thermo Electron Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,215
Award facts
- Contract value 50% obligated
-
- $5,215.20 Current, with exercised options
- $10,430.40 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockford, IL 61105, USA
Award details come from SAM.gov/FPDS.
About this award
Pierce Biotechnology Inc., a subsidiary of Thermo Electron Corporation, was awarded a Firm Fixed Price BPA call contract valued at $10,430.40 by a civilian federal agency under the Office of the Director on November 9, 2012. This contract, which has no set-aside designation, is for drugs and biologicals and will be performed in Rockford, Illinois, with an ultimate completion date of February 28, 2013. As a call against an existing Blanket Purchase Agreement vehicle, this award leverages Pierce Biotechnology's capabilities as part of Thermo Electron's broader portfolio of scientific instruments and laboratory supplies.
Thermo Electron Corporation, the parent company, is an established supplier of analytical instruments and scientific equipment to federal agencies including the Department of Health and Human Services, Department of Defense, and the Environmental Protection Agency. Pierce Biotechnology, as a subsidiary specializing in biological and chemical products, supports federal research and regulatory initiatives through the supply of biologicals and pharmaceutical products. The relatively modest ceiling value of this particular BPA call suggests it represents a discrete order for specific drugs or biologicals needed by the awarding agency, with delivery and completion targeted for early 2013.
Quick answers
Who was awarded contract HHSN26300211?
HHSN26300211 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on November 9, 2012.
How much is contract HHSN26300211 worth?
The government has obligated $5,215 on HHSN26300211. Its potential value, with all options, is $10,430.
Is contract HHSN26300211 an order under another contract?
Yes. HHSN26300211 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300211 competed?
The extent of competition for HHSN26300211 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award